United Therapeutics Corporation Accounts Payable
United Therapeutics Corporation (UTHR) had Accounts Payable of $7.10 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-02-25
- 2025-12-31: Accounts Payable, Current $7.10M.
- 2024-12-31: Accounts Payable, Current $6.00M.
- 2023-12-31: Accounts Payable, Current $5.60M.
- 2022-12-31: Accounts Payable, Current $4.10M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2025-12-31 | $7.10M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $6.00M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $5.60M 10-K · filed 2025-02-26 | |
| 2022-12-31 | $4.10M 10-K · filed 2024-02-21 | |
| 2021-12-31 | $3.80M 10-K · filed 2023-02-22 | |
| 2020-12-31 | $4.10M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $9.90M 10-K · filed 2021-02-24 | |
| 2018-12-31 | $23.10M 10-K · filed 2020-02-26 | |
| 2017-12-31 | $8.40M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $8.10M 10-K · filed 2018-02-21 | |
| 2015-12-31 | $7.50M 10-K · filed 2017-02-22 | $7.50M 10-K · filed 2016-02-25 |
| 2014-12-31 | $7.00M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $6.71M 10-K · filed 2015-02-24 | |
| 2013-06-30 | $9.38M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $10.19M 10-Q · filed 2013-04-25 | |
| 2012-12-31 | $10.20M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $10.13M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $8.70M 10-Q · filed 2012-07-26 | |
| 2012-03-31 | $8.34M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $47.26M 10-K · filed 2013-02-26 | |
| 2011-09-30 | $17.24M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $17.08M 10-Q · filed 2011-07-28 | |
| 2011-03-31 | $10.04M 10-Q · filed 2011-04-28 | |
| 2010-12-31 | $16.15M 10-K · filed 2012-02-28 | |
| 2010-09-30 | $11.30M 10-Q · filed 2010-10-28 | |
| 2010-06-30 | $9.35M 10-Q · filed 2010-07-28 | |
| 2009-12-31 | $18.75M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |